All Stories

  1. Preparation and physicochemical characterization of binary and ternary ground mixtures of carvedilol with PVP and SLS aimed to improve the drug dissolution
  2. Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation
  3. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides
  4. Peculiar effect of polyethylene glycol in comparison with triethyl citrate or diethyl phthalate on properties of ethyl cellulose microcapsules containing propranolol hydrochloride in process of emulsion-solvent evaporation
  5. WITHDRAWN: Advances in pharmaceutical development of modified-release drug formulations and products
  6. Pulmonary Drug Delivery
  7. Dissolution and solid state behaviours of carbamazepine-gluconolactone solid dispersion powders: The potential use of gluconolactone as dissolution enhancer
  8. Triamcinolone Acetonide Oromucoadhesive Paste for Treatment of Aphthous Stomatitis
  9. Particle Engineering for Improved Pulmonary Drug Delivery Through Dry Powder Inhalers
  10. Lipidic Micro- and Nano-Carriers for Pulmonary Drug Delivery-A State-of-the-Art Review
  11. Triboelectrification and dissolution property enhancements of solid dispersions
  12. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles
  13. An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices
  14. Increased dissolution rates of carbamazepine – gluconolactone binary blends processed by hot melt extrusion
  15. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol
  16. Acknowledgement of manuscript reviewers 2014
  17. Dry powder inhalers: Physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol
  18. Crystal engineering of ibuprofen using starch derivatives in crystallization medium to produce promising ibuprofen with improved pharmaceutical performance
  19. The dissolution and solid-state behaviours of coground ibuprofen–glucosamine HCl
  20. Antisolvent precipitation of novel xylitol-additive crystals to engineer tablets with improved pharmaceutical performance
  21. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type
  22. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques
  23. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP
  24. Drug release from matrix tablets: physiological parameters and the effect of food
  25. An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression
  26. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers
  27. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices
  28. The influence of vitamin E succinate on the stability of polyethylene oxide PEO controlled release matrix tablets
  29. Aqueous and hydro-alcoholic media effects on polyols
  30. The role of fillers and sodium metabisulfite on drug release from aged polyox tablets
  31. Towards a More Desirable Dry Powder Inhaler Formulation: Large Spray-Dried Mannitol Microspheres Outperform Small Microspheres
  32. Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles
  33. An Investigation into the Stabilization of Diltiazem HCl Release from Matrices Made from Aged Polyox Powders
  34. Treating mannitol in a saturated solution of mannitol: A novel approach to modify mannitol crystals for improved drug delivery to the lungs
  35. Engineered Mannitol Ternary Additives Improve Dispersion of Lactose–Salbutamol Sulphate Dry Powder Inhalations
  36. Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose
  37. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices—The use of the USP III apparatus
  38. Psyllium: a promising polymer for sustained release formulations in combination with HPMC polymers
  39. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling
  40. Theophylline Cocrystals Prepared by Spray Drying: Physicochemical Properties and Aerosolization Performance
  41. A novel sensing technique for measurement of magnitude and polarity of electrostatic charge distribution across individual particles
  42. Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: Effect of saturation degree
  43. Freeze-Dried Mannitol for Superior Pulmonary Drug Delivery via Dry Powder Inhaler
  44. Influence of lactose carrier particle size on the aerosol performance of budesonide from a dry powder inhaler
  45. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration
  46. Influence of Batch Cooling Crystallization on Mannitol Physical Properties and Drug Dispersion from Dry Powder Inhalers
  47. The Effect of Engineered Mannitol-Lactose Mixture on Dry Powder Inhaler Performance
  48. Dry powder inhalers: Mechanistic evaluation of lactose formulations containing salbutamol sulphate
  49. Nanotechnology Tools for Efficient Antibacterial Delivery to Salmonella
  50. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers
  51. Effect of carrier particle shape on dry powder inhaler performance
  52. In vitro and in vivo evaluation of insulin microspheres containing protease inhibitor
  53. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system
  54. Release Behaviour of Propranolol HCl from Hydrophilic Matrix Tablets Containing Psyllium Powder in Combination with Hydrophilic Polymers
  55. Effect of ionic strength and pH of dissolution media on theophylline release from hypromellose matrix tablets—Apparatus USP III, simulated fasted and fed conditions
  56. Improved Aerosolization Performance of Salbutamol Sulfate Formulated with Lactose Crystallized from Binary Mixtures of Ethanol—Acetone
  57. The Influence of Sodium Carboxymethylcellulose on Drug Release from Polyethylene Oxide Extended Release Matrices
  58. Development and in vitro–in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride
  59. Drug release from liquisolid systems: speed it up, slow it down
  60. The Effect of Carrier Particle size on Adhesion, Content Uniformity and Inhalation Performance of Budesonide using Dry Powder Inhalers
  61. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: The influence of agitation sequence
  62. Characterisation and Deposition Studies of Recrystallised Lactose from Binary Mixtures of Ethanol/Butanol for Improved Drug Delivery from Dry Powder Inhalers
  63. Glucosamine HCl as a new carrier for improved dissolution behaviour: Effect of grinding
  64. Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation
  65. Development of azithromycin–PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi
  66. Erratum to “To enhance dissolution rate of poorly water-soluble drugs: Glucosamine hydrochloride as a potential carrier in solid dispersion formulations” [Colloids Surf. B: Biointerf. 76 (2010) 170–178]
  67. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler
  68. Oral Extended Release Hydrophilic Matrices: Formulation and Design
  69. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique
  70. Development of pH-sensitive Insulin Nanoparticles using Eudragit L100-55 and Chitosan with Different Molecular Weights
  71. Liquisolid compacts: The effect of cosolvent and HPMC on theophylline release
  72. Influence of carrier particle size, carrier ratio and addition of fine ternary particles on the dry powder inhalation performance of insulin-loaded PLGA microcapsules
  73. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets
  74. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient
  75. Gliclazide Microcrystals Prepared by Two Methods of In Situ Micronization: Pharmacokinetic Studies in Diabetic and Normal Rats
  76. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin
  77. To enhance dissolution rate of poorly water-soluble drugs: Glucosamine hydrochloride as a potential carrier in solid dispersion formulations
  78. Control of encapsulation efficiency in polymeric microparticle system of tolmetin
  79. Solubility of Benzodiazepines in Polyethylene Glycol 200 + Water Mixtures at 303.2 K
  80. Solubility of 7-Chloro-2-methylamino-5-phenyl-3 H -1,4-benzodiazepine-4-oxide, 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2 H -1,4-benzodiazepin-2-one, and 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one in (Propane-1,2-diol + Wa...
  81. Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide)
  82. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method
  83. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats
  84. Solubility prediction of clonazepam in aqueous mixtures of ethanol, polyethylene glycol 200 and propylene glycol at 30 °C
  85. Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants
  86. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method
  87. Cogrinding as a Tool to Produce Sustained Release Behavior for Theophylline Particles Containing Magnesium Stearate
  88. Role of nanocarrier systems in cancer nanotherapy
  89. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets
  90. Solubility of Chlordiazepoxide, Diazepam, and Lorazepam in Ethanol + Water Mixtures at 303.2 K
  91. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method
  92. Role of nanocarrier systems in cancer nanotherapy
  93. A Novel Approach to Prepare Insulin-Loaded Poly (Lactic-Co-Glycolic Acid) Microcapsules and the Protein Stability Study
  94. Effect of Some Commercial Grades of Microcrystalline Cellulose on Flowability, Compressibility, and Dissolution Profile of Piroxicam Liquisolid Compacts
  95. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values
  96. The effect of process parameters on the size and morphology of poly(D,L-lactide-co-glycolide) micro/nanoparticles prepared by an oil in oil emulsion/solvent evaporation technique
  97. Dissolution enhancement of gliclazide using in situ micronization by solvent change method
  98. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology
  99. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices
  100. Development and Chemical Stability Studies of Alcohol-Free Phenobarbital Solution for Use in Pediatrics: a Technical Note
  101. Erratum: Ghafourian T, Safari A, Adibkia K, Parviz F, Nokhodchi, A. 2007. A drug Release Study from Hydroxypropylmethylcellulose (HPMC) Matrices Using QSPR Modeling. J Pharm Sci 96:3334–3351.
  102. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices
  103. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique
  104. Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water-soluble drugs
  105. Preparation of Spherical Crystal Agglomerates of Naproxen Containing Disintegrant for Direct Tablet Making by Spherical Crystallization Technique
  106. An In Vitro Evaluation of Fenugreek Mucilage as a Potential Excipient for Oral Controlled-Release Matrix Tablet
  107. Factors Affecting the Release of Nifedipine from a Swellable Elementary Osmotic Pump
  108. Solubility Prediction of Paracetamol in Water–Ethanol–Propylene Glycol Mixtures at 25 and 30 °C Using Practical Approaches
  109. Factors affecting the morphology of benzoyl peroxide microsponges
  110. A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling
  111. Inhibition of Endotoxin-Induced Uveitis by Methylprednisolone Acetate Nanosuspension in Rabbits
  112. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine)
  113. Preparation of agglomerated crystals for improving flowability and compactibility of poorly flowable and compactible drugs and excipients
  114. The effect of terpene concentrations on the skin penetration of diclofenac sodium
  115. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties
  116. Preparation and Characterization of Solid Dispersions of Piroxicam with Hydrophilic Carriers
  117. An Investigation of Physicochemical Properties of Piroxicam Liquisolid Compacts
  118. Propranolol Hydrochloride Osmotic Capsule with Controlled Onset of Release
  119. Improved Compaction and Packing Properties of Naproxen Agglomerated Crystals Obtained by Spherical Crystallization Technique
  120. Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis
  121. QSPR models for the prediction of apparent volume of distribution
  122. The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies
  123. Improvement of the dissolution rate of indomethacin by a cogrinding technique using polyethylene glycols of various molecular weights
  124. Book Review: Pharmaceutical Dissolution Testing
  125. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices
  126. The Influence of Thermal Treatment on the Release Behavior of Diclofenac Sodium from Acrylic Matrices
  127. Enhancement of dissolution rate of piroxicam using liquisolid compacts
  128. Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives
  129. The Influence of Thermal Treatment on the Release Behavior of Diclofenac Sodium from Acrylic Matrices
  130. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices
  131. The role of various surfactants on the release of salbutamol from suppositories
  132. The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices
  133. The effect of penetration enhancers on drug delivery through skin: a QSAR study
  134. Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers
  135. Physicochemical Characterization of Solid Dispersions of Indomethacin with PEG 6000, Myrj 52, Lactose, Sorbitol, Dextrin, and Eudragit® E100
  136. Crystal modification of phenytoin using different solvents and crystallization conditions
  137. The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations
  138. The enhancement effect of surfactants on the penetration of lorazepam through rat skin
  139. The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-Eudragit matrices
  140. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices
  141. Prediction of benzodiazepines solubility using different cosolvency models
  142. The effect of surfactants on the skin penetration of diazepam
  143. An Approach to Controlled-Release Dosage Form of Propranolol Hydrochloride
  144. Compression Properties of Methylcellulose and Hydroxypropylmethylcellulose Polymers
  145. Effect of Polysorbates on Atenolol Release from Film-Coated Tablets
  146. Effects of Hydrophilic Excipients and Compression Pressure on Physical Properties and Release Behavior of Aspirin-Tableted Microcapsules
  147. Effect of hydrophilic excipients and compression pressure on physical properties and release behaviour of aspirin-tableted microcapsules
  148. The effects of pH and polarity of electrode on the remaining propranolol within human skin
  149. Studies on the Interaction Between Water and (Hydroxypropyl)Methylcellulose
  150. Studies on Controlled-Release Formulations of Diclofenac Sodium
  151. The Influence of Moisture Content on the Consolidation Properties of Hydroxypropylmethylcellulose K4M (HPMC 2208)
  152. The Effect of Moisture on the Heckel and Energy Analysis of Hydroxypropylmethylcellulose 2208 (HPMC K4M)
  153. The effects of compression rate and force on the compaction properties of different viscosity grades of hydroxypropylmethylcellulose 2208
  154. The effect of particle size and viscosity grade on the compaction properties of hydroxypropylmethylcellulose 2208
  155. The effect of moisture content on the energies involved in the compaction of ibuprofen
  156. The effect of moisture on the properties of ibuprofen tablets
  157. The Dissolution